환자 혈액 관리 시장 규모, 점유율, 성장 분석 : 제품별, 컴포넌트별, 최종사용자별, 지역별 - 산업 예측(2024-2031년)
Patient Blood Management Market Size, Share, Growth Analysis, By Product (Instruments, Blood Processing Devices), By Component (Whole Blood, Blood Components), By End User, By Region - Industry Forecast 2024-2031
상품코드:1622426
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2024년 12월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
환자 혈액 관리 시장 규모는 2023년에 137억 9,000만 달러로 평가되며, 2024년 146억 6,000만 달러에서 2032년에는 239억 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 6.30%로 성장할 전망입니다.
세계의 환자 혈액 관리(PBM) 시장은 만성질환의 유병률 증가, 수술 증가, PBM의 이점에 대한 인식 증가에 힘입어 강력한 성장세를 보이고 있습니다. 이 전략적 접근 방식은 수혈이 필요한 환자의 치료를 강화하고 궁극적으로 결과를 개선하고 수혈에 대한 의존도를 최소화하는 것을 목표로 합니다. 심혈관 질환, 암, 혈액 질환과 같은 만성질환은 수혈이 필요한 수술의 주요 원인이 되고 있습니다. 그러나 의료 서비스 프로바이더들은 감염 및 면역 반응과 같은 관련 위험을 줄이기 위해 PBM 전략을 시행하고 있습니다. 이러한 변화는 수술 결과 개선과 합병증 감소에 초점을 맞추고 있으며, PBM 솔루션에 대한 시장 수요를 촉진하고 있습니다. 또한 수혈을 대체할 수 있는 혁신적인 대안에 대한 인식이 높아짐에 따라 전 세계에서 PBM 도입이 확대되고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
환자 혈액 관리 시장 규모 : 제품별
시장 개요
기기
혈액 처리 기기
원심
혈액 세포 처리 기기
수혈 기기
아페레시스 기계
세포 구제 시스템
혈액 배양 스크리닝 기기
자동 혈액 배양 시스템
지원 장비
진단 및 검사기기
중합효소 연쇄 반응
혈액 분석기
혈액형 검사 분석기
차세대 시퀀싱(NGS) 플랫폼
기타
혈액 보존 기기
냉장고
냉동고
액세서리
주사기와 바늘
바이알과 튜브
혈액 백
기타 액세서리
시약과 키트
배양 미디어
혈액형 판정 시약
슬라이드 염색
어세이 키트
기타
소프트웨어
혈액은행 및 수혈 소프트웨어
기타
환자 혈액 관리 시장 규모 : 컴포넌트별
시장 개요
전혈
혈액 성분
환자 혈액 관리 시장 규모 : 최종사용자별
시장 개요
병원
혈액은행
환자 혈액 관리 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
회사 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출의 전년대비 비교(2022-2024년)
주요 기업 개요
Haemonetics Corporation(USA)
Macopharma(France)
Terumo Corporation(Japan)
B. Braun SE(Germany)
Grifols, S.A.(Spain)
Asahi Kasei Corporation(Japan)
BioMerieux SA(France)
LivaNova PLC(UK)
Fresenius Kabi AG(Germany)
Roche Holding AG(Switzerland)
Abbott Laboratories(USA)
Bio-Rad Laboratories, Inc.(USA)
Danaher Corporation(USA)
Siemens Healthineers(Germany)
Johnson & Johnson(USA)
Medtronic plc.(Ireland)
BD(Becton, Dickinson and Company)(USA)
Cardinal Health(USA)
Teleflex Incorporated(USA)
Stryker Corporation(USA)
결론과 권장사항
KSA
영문 목차
영문목차
Patient Blood Management Market size was valued at USD 13.79 Billion in 2023 and is poised to grow from USD 14.66 Billion in 2024 to USD 23.9 Billion by 2032, growing at a CAGR of 6.30% during the forecast period (2025-2032).
The global patient blood management (PBM) market is on a robust growth trajectory, fueled by rising chronic disease prevalence, an uptick in surgical procedures, and heightened awareness of PBM benefits. This strategic approach aims to enhance care for patients needing blood transfusions, ultimately improving outcomes and minimizing transfusion reliance. Chronic diseases like cardiovascular disorders, cancer, and blood disorders are major contributors to surgical needs, intensifying transfusion requirements. However, healthcare providers are increasingly implementing PBM strategies to mitigate associated risks such as infections and immune reactions. This shift emphasizes improving surgical results and reducing complications, propelling market demand for PBM solutions. Furthermore, awareness of innovative alternatives to transfusions is increasingly promoting the adoption of PBM practices on a global scale.
Top-down and bottom-up approaches were used to estimate and validate the size of the Patient Blood Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Patient Blood Management Market is segmented by product, component, end user and region. Based on product, the market is segmented into instruments, blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, blood storage devices, accessories, syringes & needles, vials & tubes, blood bags, other accessories, reagents and kits, culture media, blood typing reagents, slide staining, assay kits, others, software, blood bank and transfusion software and others. Based on component, the market is segmented into whole blood and blood components. Based on end user, the market is segmented into hospitals and blood banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Patient Blood Management Market
The Patient Blood Management market is driven by significant advancements in transfusion medicine, which have transformed the landscape of blood management practices. Innovations in techniques and technologies have greatly enhanced the safety, efficiency, and effectiveness of blood transfusions. As a result, healthcare providers are increasingly embracing patient blood management strategies to optimize patient outcomes. These developments not only reduce the risks associated with transfusions but also foster a greater understanding of the importance of prudent blood usage. Consequently, the ongoing evolution in transfusion medicine is playing a pivotal role in propelling the growth of the Patient Blood Management market.
Restraints in the Patient Blood Management Market
The Patient Blood Management market faces several restraints, primarily due to the challenges associated with altering established transfusion practices. Transitioning towards these new management strategies requires a significant shift away from traditional methods and medical standards. This shift can be hindered by resistance to change from healthcare professionals, as well as the need to accommodate individual physician preferences. Moreover, ensuring that adequate training and education are provided to facilitate understanding and acceptance of these innovative practices poses additional hurdles. As a result, these factors collectively impede the broader implementation and acceptance of patient blood management methodologies in clinical settings.
Market Trends of the Patient Blood Management Market
In the global Patient Blood Management market, a notable trend is the heightened emphasis on personalized and evidence-based transfusion practices, driven by a growing awareness of the risks associated with indiscriminate blood use. Healthcare providers are increasingly adopting tailored transfusion strategies that align with individual patient needs and clinical conditions, steering away from the traditional one-size-fits-all approach. This shift not only aims to enhance patient safety by reducing the likelihood of transfusion reactions and infections but also seeks to lower healthcare costs through optimized blood utilization. Consequently, hospitals and healthcare systems are investing in technologies and training that support this patient-centric model, indicating a transformational shift in blood management practices.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Patient Blood Management Market Size by Product & CAGR (2025-2032)
Market Overview
Instruments
Blood Processing Devices
Centrifuge
Blood Cell Processors
Blood Transfusion Devices
Apheresis Machines
Cell Salvage Systems
Blood Culture Screening Devices
Automated Blood Culture Systems
Supporting Equipment
Diagnostic & Testing Instruments
Polymerase Chain Reaction
Hematology Analyzer
Blood Grouping Analyzers
Next-Generation Sequencing (Ngs) Platforms
Others
Blood Storage Devices
Refrigerator
Freezers
Accessories
Syringes & Needles
Vials & Tubes
Blood Bags
Other Accessories
Reagents And Kits
Culture Media
Blood Typing Reagents
Slide Staining
Assay Kits
Others
Software
Blood Bank And Transfusion Software
Others
Global Patient Blood Management Market Size by Component & CAGR (2025-2032)
Market Overview
Whole Blood
Blood Components
Global Patient Blood Management Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals
Blood Banks
Global Patient Blood Management Market Size & CAGR (2025-2032)
North America (Product, Component, End User)
US
Canada
Europe (Product, Component, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product, Component, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product, Component, End User)
Brazil
Rest of Latin America
Middle East & Africa (Product, Component, End User)
